218 Results

People

  1. Papanicolaou
    Papanicolaou
  2. Perales
    Perales
  3. Giralt
    Giralt
  4. Seo
    Seo
  5. Papadopoulos
    Papadopoulos
  6. Shaffer
    Shaffer
  7. Jakubowski
    Jakubowski
  8. Kernan
    Kernan
  9. Sepkowitz
    Sepkowitz
  10. Amar
    Amar

Groups

  1. Department of Medicine (112)
  2. Division of Subspecialty Medicine (53)
  3. Hematologic Malignancies, Division of (52)
  4. Center for Hematologic Malignancies (50)
  5. Survivorship Research (33)
  6. Bone Marrow Transplant (32)
  7. Infectious Disease (30)
  8. Surgery (27)
  9. Epidemiology and Biostatistics (23)
  10. Solid Tumor Oncology Division (22)
  1. "prophylaxis"
Formats
  1. Journal Article (190)
  2. Review (15)
  3. Guidelines (4)
  4. Research Letter (4)
  5. Correspondence (2)
  6. Conference Paper (1)
  7. Editorial (1)
  8. Meeting Abstract (1)
Groups
  1. Department of Medicine (112)
  2. Division of Subspecialty Medicine (53)
  3. Hematologic Malignancies, Division of (52)
  4. Center for Hematologic Malignancies (50)
  5. Survivorship Research (33)
  6. Bone Marrow Transplant (32)

More Groups

People
  1. Genovefa Papanicolaou (17)
  2. Miguel-Angel Perales (13)
  3. Sergio Giralt (12)
  4. Susan Seo (11)
  5. Brian Shaffer (8)
  6. Esperanza Papadopoulos (8)

More People

Years
  1. 2025 (11)
  2. 2024 (19)
  3. 2023 (15)
  4. 2022 (8)
  5. 2021 (8)
  6. 2020 (9)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (9)
  2. Transplantation and Cellular Therapy (9)
  3. Blood (7)
  4. Cancer (7)
  5. Journal of Clinical Oncology (6)
  6. Journal of the National Comprehensive Cancer Network (6)

More Publications

Publishers
  1. Elsevier Inc. (42)
  2. Wiley Blackwell (17)
  3. Elsevier Science, Inc. (12)
  4. American Society of Hematology (11)
  5. Lippincott Williams & Wilkins (11)
  6. Oxford University Press (11)

More Publishers

Results (218)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre-emptive monitoring in the era of letermovir
    Review

    Yong, M. K.; Slavin, M. A.; Chemaly, R. F.; Papanicolaou, G. A.
    Transplant Infectious Disease (2023)

    Fulltext@MSK | Save
  • Phase Ib/II study of the efficacy and safety of binimetinib (MEK162) plus panitumumab for mutant or wild-type RAS metastatic colorectal cancer
    Journal Article

    Van Cutsem, E.; Yaeger, R.; Delord, J. P.; Tabernero, J.; Siu, L. L.; Ducreux, M.; Siena, S.; Elez, E.; Kasper, S.; Zander, T.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant
    Journal Article

    Lin, A.; Brown, S.; Chinapen, S.; Lee, Y. J.; Seo, S. K.; Ponce, D. M.; Shahid, Z.; Giralt, S.; Papanicolaou, G. A.; Perales, M. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Venous thromboembolism prophylaxis for hospitalized adult patients: A survey of US health care providers on attitudes and practices
    Journal Article

    Lam, B. D.; Dodge, L. E.; Datta, S.; Rosovsky, R. P.; Robertson, W.; Lake, L.; Reyes, N.; Adamski, A.; Abe, K.; Panoff, S.; more...
    Research and Practice in Thrombosis and Haemostasis (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): Phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
    Journal Article

    Rubinstein, P. G.; Moore, P. C.; Bimali, M.; Lee, J. Y.; Rudek, M. A.; Chadburn, A.; Ratner, L.; Henry, D. H.; Cesarman, E.; DeMarco, C. E.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
    Review

    Perissinotti, A. J.; Bishop, M. R.; Bubalo, J.; Geyer, M. B.; Goodrich, A.; Howard, S. C.; Kula, J.; Mandayam, S.; Cairo, M. S.; Pui, C. H.
    Cancer Treatment Reviews (2023)

    Fulltext@MSK | Save
  • HLA class I genotype is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated acute myeloid leukemia
    Journal Article

    Narayan, R.; Niroula, A.; Wang, T.; Kuxhausen, M.; He, M.; Meyer, E.; Chen, Y. B.; Bhatt, V. R.; Beitinjaneh, A.; Nishihori, T.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant
    Review

    Garcia-Rosa, M.; Abraham, A.; Bertaina, A.; Bhoopalan, S. V.; Bonfim, C.; Cohen, S.; DeZern, A.; Louis, C.; Oved, J.; Pavel-Dinu, M.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects
    Journal Article

    Nakamura, Z. M.; Deal, A. M.; Park, E. M.; Stanton, K. E.; Lopez, Y. E.; Quillen, L. J.; O’Hare Kelly, E.; Heiling, H. M.; Nyrop, K. A.; Ray, E. M.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • American Society for Transplantation and Cellular Therapy series, #6: Management of invasive candidiasis in hematopoietic cell transplantation recipients
    Guidelines

    Neofytos, D.; Steinbach, W. J.; Hanson, K.; Carpenter, P. A.; Papanicolaou, G. A.; Slavin, M. A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save